featured
DUTCH PEERS: Third-Generation Zotarolimus-Eluting vs Everolimus-Eluting Stents for PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Third-Generation Zotarolimus-Eluting and Everolimus-Eluting Stents in All-Comer Patients Requiring a Percutaneous Coronary Intervention (DUTCH PEERS): A Randomised, Single-Blind, Multicentre, Non-Inferiority Trial
Lancet 2014 Feb 01;383(9915)413-423, C von Birgelen, H Sen, MK Lam, PW Danse, GA Jessurun, RW Hautvast, GK van Houwelingen, AR Schramm, RM Gin, JW Louwerenburg, FH de Man, MG Stoel, MM Löwik, GC Linssen, SA Saïd, MB Nienhuis, PM Verhorst, MW Basalus, CJ Doggen, K TandjungFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.